Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents

The absence of biomarkers to accurately predict anticancer therapy response remains a major obstacle in clinical oncology. We applied a genome‐wide loss‐of‐function screening approach in human haploid cells to characterize genetic vulnerabilities to classical microtubule‐targeting agents. Using doce...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerhards, Nora M., Blomen, Vincent A., Mutlu, Merve, Nieuwenhuis, Joppe, Howald, Denise, Guyader, Charlotte, Jonkers, Jos, Brummelkamp, Thijn R., Rottenberg, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983209/
https://www.ncbi.nlm.nih.gov/pubmed/29689640
http://dx.doi.org/10.1002/1878-0261.12307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983209/
https://www.ncbi.nlm.nih.gov/pubmed/29689640
http://dx.doi.org/10.1002/1878-0261.12307

Ejemplares similares